CHINA SCAR TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

China Scar Treatment Market Size and Forecast – 2026 to 2033

The China Scar Treatment Market is anticipated to grow at a CAGR of 11.5% with USD 444.4 Mn in 2026 and is expected to reach USD 1,070.7 Mn in 2033. Consumers in China are increasing demand for scar treatment solutions as they seek aesthetic procedures, advanced skincare products, and improved appearance outcomes. Approximately 20 Mn people in China undergo cosmetic procedures annually, with women accounting for about 80% of patients and the average patient age around 25 years. About 82% of consumers prefer non-surgical treatments, such as injectables, over invasive surgical procedures.

Key Takeaways

• Topical Scar Products hold the largest market share of 41.6% in 2026 owing to its rising incidence of acne scars and skin concerns. According to Dermatology Practical & Conceptual, about 95% of people with acne develop some degree of scarring, which, along with active acne, can significantly impact psychosocial well-being.
• Laser expected to hold largest market share of 38.9% in 2026 owing to the rapid growth of China’s medical aesthetics industry. Laser cosmetic procedures have grown rapidly in popularity, with treatments increasing by 248% between 2000 and 2018 and reaching approximately 600,000 annually in the US by 2026.
• Clinics acquired the largest market share of 42.2% in 2026 owing to the expansion of China’s medical aesthetics industry. Approximately 20 Mn people in China undergo cosmetic procedures each year.

Current Events and Their Impact on the China Scar Treatment Market

Segmental Insights 

Why is Topical Scar Products Acquiring the Largest Market Share?

Topical Scar Products hold the largest market share of 41.6% in 2026. Consumers are driving the growth of topical scar products in China’s scar treatment market by increasing their focus on skin health and seeking non-invasive scar management solutions. Rising concerns about acne scars, surgical scars, and injury-related marks are encouraging greater product adoption. Younger consumers are showing stronger interest in beauty and skincare, while e-commerce expansion, product innovation, and higher disposable income are improving market access. Silicone gels, scar creams, and advanced skincare formulations are enabling consumers to manage scars conveniently through home-based treatments. For instance, Galderma announced the U.S. availability of EPSOLAY (benzoyl peroxide) Cream, 5% after FDA approval. EPSOLAY is the first microencapsulated benzoyl peroxide treatment proven to provide rapid and sustained relief from rosacea bumps and blemishes.

Laser holds the Largest Market Share

Laser expected to hold largest market share of 38.9% in 2026 owing to the rising demand for cosmetic appearance enhancement. Consumers and healthcare providers are accelerating the growth of laser treatment in China’s scar treatment market by increasing demand for advanced aesthetic procedures and minimally invasive solutions. Growing awareness of skin appearance encourages patients to seek effective treatments for acne scars, surgical scars, and trauma-related scars. Dermatology clinics are expanding their laser treatment offerings, while technological advancements in laser devices and the growth of medical aesthetics services are improving adoption. Rising spending on cosmetic treatments further strengthens the use of laser-based scar management procedures. China's medical aesthetics market was valued at CNY 200 billion in 2021 and is projected to reach CNY 400 billion by 2025.

Which Distribution Channel segment dominates the market? 

Clinics acquired the largest market share of 42.2% in 2026. Consumers and healthcare providers are driving the growth of clinics in China’s scar treatment market by increasing demand for professional scar management services and advanced dermatological procedures. China has more than 13,000 licensed medical aesthetic clinics operating across the country. Rising aesthetic awareness encourages patients to seek personalized treatments for acne scars, surgical scars, and injury-related scars, resulting in more clinic visits. Medical aesthetics centers are expanding their services, while advanced technologies, skilled specialists, and expert-led care improve treatment adoption. Clinics are also using digital marketing and enhanced healthcare access to attract and serve more patients.

China Scar Treatment Market Trends

• China’s medical aesthetics sector has experienced rapid growth, with minimally invasive procedures accounting for a significant share of aesthetic treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS) Global Survey, China ranked among the world’s largest markets for aesthetic procedures, with millions of non-surgical aesthetic procedures performed annually, including energy-based treatments and injectables. This growth supports increased adoption of non-surgical scar treatments such as laser therapy, microneedling, radiofrequency, and injectable approaches.
• According to ISAPS data, energy-based skin treatments remain among the most commonly performed non-surgical aesthetic procedures globally, reflecting continued demand for technologies such as fractional lasers and other light-based devices. International Society of Aesthetic Plastic Surgery (ISAPS) Global Survey Fractional CO₂ lasers, pulsed dye lasers, and picosecond lasers are widely used in China for acne scars, traumatic scars, burn scars, and post-inflammatory pigmentation management.
• China has one of the world’s largest digital consumer markets. According to the China Internet Network Information Center (CNNIC) Statistical Report on Internet Development in China, China had more than 1 billion internet users, supporting the expansion of online health information, digital consultations, and e-commerce access for dermatology and aesthetic products, including scar care products.

Who are the Major Companies in China Scar Treatment Industry

Some of the major key players in China Scar Treatment are Cynosure, Inc., Syneron Medical Ltd., Mölnlycke Health Care, Ostar Beauty Sci-Tech Co., Ltd., Shanghai Fosun Pharmaceutical Co. Ltd., Beijing Toplaser Technology Co., Ltd., Merz Pharma, and Luca Pharmaceuticals.

Key News

• In October 2025, Boehringer Ingelheim received NMPA approval for JASCAYD (nerandomilast) as an oral treatment for idiopathic pulmonary fibrosis (IPF) in adults in China, marking the first IPF approval in over a decade.

Market Report Scope

Analyst Opinion

• The China scar treatment market is shifting from corrective care to proactive aesthetic management, driven by rising consumer expectations rather than only medical necessity. In my view, the strongest growth opportunity lies in younger consumers seeking solutions for acne scars and appearance-related skin concerns. China has one of the world’s largest skincare consumer bases, and the increasing influence of social media platforms such as Xiaohongshu and Douyin is accelerating demand for visible skin improvement. Acne affects a significant proportion of adolescents and young adults globally, with studies commonly reporting prevalence levels above 80% in teenagers, creating a large population vulnerable to post-acne scarring and long-term scar management needs.
• China’s growing medical aesthetics industry is acting as the primary catalyst for advanced scar treatment adoption, with clinics becoming the key decision-making point for consumers. More patients are combining scar treatments with other aesthetic procedures, including laser resurfacing, microneedling, injectables, and regenerative therapies. According to industry estimates, China has thousands of licensed medical aesthetic institutions, with private aesthetic chains and dermatology centers expanding services beyond major cities. This trend indicates that scar treatment is evolving into a specialized aesthetic service category rather than remaining limited to hospitals and dermatology departments.
• Topical scar products will continue to maintain strong consumer demand because they offer accessibility and convenience, but differentiation will depend heavily on clinical credibility and formulation innovation. Chinese consumers are becoming more ingredient-conscious and increasingly seek products containing clinically recognized components such as silicone, which is widely recommended for managing hypertrophic and surgical scars.
• Post-surgical scar management represents an underpenetrated opportunity as cosmetic procedures and elective surgeries continue to increase in China. With growing acceptance of cosmetic procedures, patients are becoming more focused on improving surgical outcomes, including scar appearance after procedures.

Market Segmentation

• By Product Type (Revenue, USD Mn, 2021-2033)
  • Topical Scar Products
    • Cream
    • Oil
    • Gel
    • Gel Sheet
    • Elastic Wraps
    • Sprays
  • Aesthetic Lasers
  • Others
• By Treatment (Revenue, USD Mn, 2021-2033)
  • Topical
  • Laser
  • Invasive Surgical
  • Others
• By Distribution Channel (Revenue, USD Mn, 2021-2033)
  • Hospitals
  • Clinics
  • OTC

Sources

Primary Research Interviews

• Dermatologists, cosmetic surgeons, and aesthetic medicine specialists in China
• Key opinion leaders (KOLs) in dermatology and scar management
• Hospital and clinic representatives providing scar treatment services
• Manufacturers and distributors of scar treatment products and devices
• Patients and end-users using scar treatment solutions

Databases

• National healthcare databases and public health statistics platforms
• Government healthcare and medical device registration databases
• Clinical trial databases
• Scientific and biomedical literature databases
• Trade and import-export databases related to medical devices and pharmaceuticals

Magazines

• Dermatology and aesthetic medicine magazines
• Healthcare industry publications
• Medical technology and innovation magazines
• Beauty and wellness industry publications

Journals

• Peer-reviewed dermatology journals
• Plastic and reconstructive surgery journals
• Aesthetic medicine journals
• Wound healing and scar management research journals
• Biomedical and pharmaceutical research journals

Newspapers

• National and regional healthcare news publications
• Business and economic newspapers covering healthcare trends
• Medical technology and pharmaceutical news sources
• Public health and regulatory updates from news outlets

Associations

• Dermatology associations
• Plastic surgery associations
• Medical aesthetics associations
• Wound care and tissue repair organizations
• Healthcare professional societies

Public Domain Sources

• Government healthcare reports and statistics
• Regulatory authority publications
• Medical device and pharmaceutical approval records
• Hospital and healthcare institution publications
• Academic research repositories
• International health organization reports
• Open-access scientific publications

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 10 years